6-(2,4-Dichlorophenyl)-5-[4-[(3S)-1-(3-Fluoropropyl)Pyrrolidin-3-Yl]Oxyphenyl]-8,9-Dihydro-7H-Benzo[7]Annulene-2-Carboxylic Acid For Use In Metastatic Or Advanced Breast Cancer Patients

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20240091194A1
SERIAL NO

18241419

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The compound 6-(2,4-dichlorophenyl)-5-[4-[(3S)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7H-benzo[7]annulene-2-carboxylic acid, or a pharmaceutically acceptable salt thereof, for use in the treatment of metastatic or advanced breast cancer at a dose of 150 to 600 mg per day.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SANOFIPARIS

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Anneheim-Herbelin, Sandrine Paris, FR 1 1
CARTOT-COTTON, Sylvaine Paris, FR 3 3
CELANOVIC, Marina Bridgewater, US 3 3
COHEN, Patrick Paris, FR 12 47
PAUX, Gautier Bridgewater, US 3 3

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation